Back
Pharming Group 10K Form
Sell
24
PHAR
Pharming Group
Last Price:
$8.17
Seasonality Move:
-14.93%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PHAR News And Ratings
See the #1 stock for the next 7 days that we like better than PHAR
PHAR Financial Statistics
Sales & Book Value
| Annual Sales: | $297.2M |
|---|---|
| Cash Flow: | $9.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.27 |
| Price / Book: | 2.49 |
Profitability
| EPS (TTM): | -0.16000 |
|---|---|
| Net Income (TTM): | $-11M |
| Gross Margin: | $261.8M |
| Return on Equity: | -5.03% |
| Return on Assets: | -2.56% |
Pharming Group Earnings Forecast
Key Pharming Group Financial Ratios
-
The Gross Profit Margin over the past 19 years for PHAR is 88.09%.
-
The Selling, General & Administrative Expenses for PHAR have been equal to 33.38% of Gross Profit Margin.
-
The Research & Development expenses have been 27.98% of Revenue.
-
The Net Earning history of PHAR is -3.98% of Total Revenues.
-
Per Share Earnings over the last 20 years have been positive in 8 years.
Pharming Group Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PHAR |
| Website: | pharming.com |
Debt
| Debt-to-Equity Ratio: | 0.37 |
|---|---|
| Current Ratio: | 3.78 |
| Quick Ratio: | 3.02 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 2300 |
PHAR Technical Analysis vs Fundamental Analysis
Sell
24
Pharming Group (PHAR)
is a Sell
Is Pharming Group a Buy or a Sell?
-
Pharming Group stock is rated a SellThe current Pharming Group [PHAR] share price is $8.05. The Score for PHAR is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.